Millions of people worldwide are affected by conditions such as vascular lesions, rosacea, acne, and melasma—often impacting their confidence and quality of life. ADVATx offers a proven, effective solution, helping to address these concerns and support overall skin health.
With its dual-wavelength technology, ADVATx treats a broad range of indications, making it a leading choice for clinicians seeking advanced, versatile solutions. Join the thousands of practices already using ADVATx to deliver comprehensive care across 25 FDA- and CE-cleared indications.
ADVATx effectively treats some of the most in-demand and challenging indications.
Elevate your practice with its proven, innovative approach to patient care.
ADVATx safely treats a wide range of vascular conditions with no patient downtime. The 589nm wavelength is selectively absorbed by oxyhaemoglobin, allowing it to effectively target vascular concerns without causing bruising or purpura.
Using both 589nm and 1319nm wavelengths, ADVATx targets active acne by reducing porphyrins in the skin while delivering controlled thermal energy to the sebaceous glands, helping to regulate oil and sebum production.
ADVATx helps gradually reduce the appearance of scars with successive treatments. The 589nm wavelength diminishes redness and definition, while the 1319nm wavelength stimulates collagen production, refining texture over time.
ADVATx targets melasma by addressing vascular components with the 589nm wavelength while supporting sebaceous activity using the 1319nm wavelength. This dual approach delivers effective results with low risk of post-inflammatory hyperpigmentation.
ADVATx treats rosacea by targeting vascular irregularities with the 589nm wavelength while improving skin texture using the 1319nm wavelength. This dual approach reduces redness effectively and supports a clearer, more even complexion.
ADVATx treats pigmentation by targeting brown pigment and redness with the 589nm wavelength while enhancing safety and comfort using the 1319nm wavelength. This dual approach supports consistent results across a wide range of skin types.
Using dual wavelengths, ADVATx targets superficial vasculature, triggering a controlled inflammatory response while delivering thermal energy to the papillary dermis. This process stimulates the body’s natural healing response, activates fibroblasts, and promotes the production of Type I and III collagen—visibly improving skin tone and texture.
*CE-Cleared Indication
Approved for
Skin Types I-V
With numerous FDA and CE-cleared indications ranging from vascular abnormalities to acne, wrinkle reduction and warts, ADVATx is poised to become the laser modality of choice for physicians dedicated to offering their patients the most advanced laser solutions available.
































